ArticleJournal of clinical pharmacology2017

PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers.

Greg Coffey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.